AI Adoption

Twitter

Facebook

Copy Link

Top News

AstraZeneca's $555 Million AI-Powered Gene-Editing Deal with Algen Biotechnologies

AstraZeneca signs a $555 million deal with Algen Biotechnologies to develop AI-driven gene-editing therapies, marking a significant step in the pharmaceutical industry's adoption of AI for drug discovery.

Technology2 sources

AstraZeneca's $555 Million AI-Powered Gene-Editing Deal with Algen Biotechnologies

Technology2 sources

Nintendo Denies AI Lobbying Claims, Reaffirms IP Protection Stance

Nintendo has officially denied rumors of lobbying against generative AI with the Japanese government. The company clarifies its position on AI use and intellectual property protection.

Policy2 sources

Nintendo Denies AI Lobbying Claims, Reaffirms IP Protection Stance

Policy2 sources

Prev 1…131 132 133134Next